Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-… (NCT06906627) | Clinical Trial Compass
RecruitingNot Applicable
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
United States750 participantsStarted 2025-10-28
Plain-language summary
IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Screening Program-
Inclusion Criteria:
* Adults with type 2 diabetes (T2D)
* Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP).
* Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR
Exclusion Criteria:
• Chronic kidney disease (CKD) diagnosis
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on improving how CKD is screened and managed in people with type 2 diabetes — does it actually involve any new treatments, or would I just be participating in changes to how my care team monitors and tests me?
2Since this is listed as 'Phase NA,' which suggests it's a healthcare improvement or implementation study rather than a drug or device trial, what does that mean for my personal safety risks compared to a traditional clinical trial?
3The trial is measuring something called a 'CKD Screening Lab Opportunity Score' — can you explain what that means in practice, and whether participating would change how often I get kidney function tests like eGFR or urine albumin?
4If I already have a routine monitoring plan for both my type 2 diabetes and my kidneys, how would joining this program be different from the standard care I'm already receiving?
5Would taking part in this implementation program in any way delay or replace access to established treatments for CKD or type 2 diabetes that might be more directly beneficial to me right now?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.